You are here

Home

Medical - global

Primary tabs

Sat, 2013-06-22 21:44 — Gina Angiola
The medical working group is focused on issues that affect delivery of medical care to those in need

The medical working group seeks to address issues affecting delivery of medical care to those in need.

Add Content to this group

Click to add a new Group Post Simple to this group
Click to add a new Group Post Simple w Images to this group
Click to add a new Group Post to this group
Click to add a new PRIVATE Group Post to this group
Click to add a new TASK to this group

Members

Dr Ojia Adamolekun LadyCath mike kraft
Subscribe to group

Email address for group

medical-global@m.resiliencesystem.org

12 key symptoms define long Covid, new study shows, bringing treatments closer

Thu, 2023-05-25 16:47 — mike kraft
Government-funded study creates first symptom-based long Covid definition, a step toward finding treatments | CNN After more than two years and an investment of nearly $1.2 billion, researchers say they’ve come up with a list of 12 symptoms that can reliably classify someone as having long Covid, a working definition that should accelerate research into the disabling condition. CNN
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Symptoms
Treatments
Disease
Government
Health
Pandemics
Public Attitudes
Public Health
Research
Science
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

COVID pill Paxlovid gets full FDA approval after more than a year of emergency use

Thu, 2023-05-25 16:42 — mike kraft
COVID pill Paxlovid gets full FDA approval after more than a year of emergency use U.S. health regulators have given full approval to Pfizer’s COVID-19 pill Paxlovid. Thursday's action means the drug has now been fully vetted by the U.S. government and can remain on the market indefinitely. Millions of Americans have received Paxlovid since it was granted emergency authorization in late 2021. It’s become the go-to treatment for adults and older children. The FDA’s approval is only for adults who are at high risk of hospitalization or death from COVID-19. The drug is still available for children under emergency use. AP NEWS
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Treatments
Disease
Government
Health
Public Health
Research
Problem, Solution, SitRep, or ?: 
Situation Report

Air pollution exposure linked to severe COVID-19 outcomes--study

Thu, 2023-05-25 16:36 — mike kraft
Air pollution exposure linked to severe COVID-19 outcomes CIDRAP

Air pollution exposure is associated with a higher risk of experiencing severe outcomes from COVID-19 infections, including intensive care unit (ICU) admissions and death, according to new evidence in Nature Communications from the Barcelona Institute for Global Health (ISGlobal).

...

Country / Region Tags: 
Europe
Global
Spain
General Topic Tags: 
COVID-19
Symptoms
Disease
Public Health
Pollution
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Cognitive behavioral therapy reduces severe fatigue in long-COVID patients --Dutch study

Tue, 2023-05-09 19:25 — mike kraft
Cognitive behavioral therapy reduces severe fatigue in long-COVID patients Cognitive behavioral therapy lessens fatigue and improves concentration among long-COVID patients. CIDRAP
Country / Region Tags: 
Europe
Global
General Topic Tags: 
COVID-19
Symptoms
Treatments
Disease
Health
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis

Antibodies spiked then waned after Pfizer, Moderna COVID vaccines, but J&J response was opposite

Tue, 2023-05-09 18:06 — mike kraft
Antibodies spiked then waned after Pfizer, Moderna COVID vaccines, but J&J response was opposite CIDRAP

...

One month after COVID-19 vaccination, compared with J&J recipients, nAB levels were 51 times higher among Moderna recipients and 21 times higher among Pfizer recipients. At 6 months, however, J&J vaccinees produced the same antibody response as that of Moderna and significantly higher concentrations than those of Pfizer.

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Boosters
Data
Disease
Disease Prevention
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis

China's CanSinoBIO's inhaled COVID booster reported stronger against BA.1 Omicron subvariant than Sinovac shot

Tue, 2023-05-09 10:21 — mike kraft
CanSinoBIO's inhaled COVID booster stronger against BA.1 Omicron subvariant than Sinovac shot Chinese vaccine firm CanSino Biologic's inhalation-based candidate elicited a better antibody response as a booster against the BA.1 Omicron sub-variant than Sinovac's shot, but the antibody level dropped in months, clinical trial data showed. Reuters R
Country / Region Tags: 
China
Global
General Topic Tags: 
COVID-19
Treatments
Disease Prevention
Medical Testing
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis

Immune cells—not antibodies—cause rare cases of COVID vaccine-linked myocarditis --study

Mon, 2023-05-08 17:40 — mike kraft
Study: Immune cells—not antibodies—cause COVID vaccine-linked myocarditis The rare cases of myocarditis among recipients of mRNA vaccines are caused by a generalized immune-cell and inflammatory response, researchers say. CIDRAP
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Symptoms
Demographics
Disease
Health
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis

Anxiety, depression may play a role in long COVID, including physical issues

Mon, 2023-05-08 17:30 — mike kraft
Anxiety, depression may play a role in long COVID - UPI.com In trying to untangle the mysteries of long COVID, researchers have found anxiety and depression may play a role for some of those with the lingering condition. UPI

In the study from researchers at University of California, Los Angeles (UCLA), patients who perceived that they had thinking difficulties during COVID-19 infection were also more likely to have lingering physical symptoms than those who did not report thinking issues.

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Symptoms
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis

Paxlovid slashed risk of COVID hospital stay in unvaccinated patients -- Canadian study

Mon, 2023-05-08 17:12 — mike kraft
Paxlovid slashed risk of COVID hospital stay in some patients amid Omicron, study suggests CIDRAP

The antiviral drug Paxlovid was tied to a 96% lower relative risk (RR) of COVID-19 hospitalization among high-risk outpatients who didn't complete a primary vaccination series but didn't benefit those who had received at least two doses amid the SARS-CoV-2 Omicron variant, according to a real-world study published yesterday in Clinical Infectious Diseases.

....

Country / Region Tags: 
Canada
Global
General Topic Tags: 
COVID-19
Symptoms
Treatments
Data
Disease
Health
Hospitals
Medical Testing
Pandemics
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Analysis: Research into treating long COVID is stuck

Mon, 2023-05-08 09:42 — mike kraft
Long COVID Treatment Research Is Stuck in a Frustrating Catch-22 Patients are feeling abandoned, for good reason. Liz Highleyman Slate Magazine

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Symptoms
Treatments
Government
Health
Public Health
Research
Science
Problem, Solution, SitRep, or ?: 
Analysis
Problem

Pages

howdy folks
Page loaded in 0.882 seconds.